Ingevity (NGVT) EBITDA Margin (2016 - 2025)
Ingevity (NGVT) has disclosed EBITDA Margin for 11 consecutive years, with 14.83% as the latest value for Q4 2025.
- On a quarterly basis, EBITDA Margin fell 1373.0% to 14.83% in Q4 2025 year-over-year; TTM through Dec 2025 was 21.33%, a 83.0% increase, with the full-year FY2025 number at 21.33%, down 218.0% from a year prior.
- EBITDA Margin was 14.83% for Q4 2025 at Ingevity, down from 21.95% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 33.94% in Q4 2023 to a low of 10.19% in Q4 2022.
- A 5-year average of 20.94% and a median of 21.69% in 2022 define the central range for EBITDA Margin.
- Peak YoY movement for EBITDA Margin: soared 2374bps in 2023, then plummeted -1373bps in 2025.
- Ingevity's EBITDA Margin stood at 14.88% in 2021, then plummeted by -32bps to 10.19% in 2022, then soared by 233bps to 33.94% in 2023, then dropped by -16bps to 28.56% in 2024, then crashed by -48bps to 14.83% in 2025.
- Per Business Quant, the three most recent readings for NGVT's EBITDA Margin are 14.83% (Q4 2025), 21.95% (Q3 2025), and 26.9% (Q2 2025).